Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Sep 11, 2009

NEW YORK (GenomeWeb News) – 23andMe Co-founder Linda Avey has left the personal genomics services company to start a foundation that will focus on Alzheimer's disease. The foundation Avey will run will use the 23andMe research platform to search for causes of and treatments for the disease.

Avey's departure was effective as of Sept. 4, the day the announcement was made.

Avey and co-founder Anne Wojcicki started the company together around three years ago.

Mario Caccamo has been named head of bioinformatics for The Genome Analysis Centre in the UK. Caccamo worked until recently at the European Genome-Phenome Archive. The centre also recently appointed Amanda McMurray to be business development director.

DxS has appointed Patrik Dahlen to serve as a non-executive director. Dahlen formerly was CEO of cancer diagnostics firm Dako and CEO of BioImage, as well as president of life sciences and senior VP of PerkinElmer.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.